Nascent Biotech (NBIO) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free NBIO Stock Alerts $0.10 +0.01 (+11.12%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNascent Biotech prepares for pivotal Phase II research with fresh manufacturing runmsn.com - April 16 at 3:45 PMNascent Biotech Inc.: Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Runfinanznachrichten.de - April 16 at 8:23 AMNascent Biotech, Inc. (OTCMKTS:NBIO) Short Interest Up 21.8% in Marchamericanbankingnews.com - April 15 at 6:18 AMNascent Biotech Inc.: Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery Systemfinanznachrichten.de - March 19 at 12:57 PMNascent Biotech Inc NBIOmorningstar.com - March 2 at 2:35 PMNascent Biotech Inc.: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugatesfinanznachrichten.de - February 6 at 10:09 AMNascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugatesfinance.yahoo.com - February 6 at 10:09 AMNascent Biotech Inc.: Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valuedfinanznachrichten.de - January 10 at 8:43 AMNascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valuedfinance.yahoo.com - January 9 at 9:25 AMNascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Riskfinance.yahoo.com - December 19 at 12:10 PMNascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrierfinance.yahoo.com - November 29 at 9:37 AMIsana Nascent Academyusnews.com - November 15 at 8:20 PMChicago to showcase its biotech sector at capital summit next weekbizjournals.com - October 26 at 6:07 PMA tropical storm could threaten Florida next week. Here’s what we know.washingtonpost.com - September 2 at 5:04 AMNascent Biotech to Begin Phase II Clinical Trials for Brain Cancerfinance.yahoo.com - August 22 at 8:18 AMNascent Biotech Inc.: Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual Meetingfinanznachrichten.de - June 7 at 9:46 AMNascent Biotech Inc.: Nascent Biotech Regains Worldwide Rights for Pritumumabfinanznachrichten.de - May 26 at 7:13 PMNascent Biotech Regains Worldwide Rights for Pritumumabfinance.yahoo.com - May 26 at 7:13 PMNascent Biotech Inc.: Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meetingfinanznachrichten.de - May 9 at 10:52 AMNascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meetingfinance.yahoo.com - May 9 at 10:52 AMNascent Biotech Inc.: Nascent Submits Phase 2 Clinical Research Protocol to FDA for Review and Approvalfinanznachrichten.de - April 18 at 9:57 AMNascent Submits Phase 2 Clinical Research Protocol to FDA for Review and Approvalfinance.yahoo.com - April 18 at 9:57 AMNascent Biotech Inc.: Nascent Announces the Completion of Its Phase1 Clinical Trialsfinanznachrichten.de - February 28 at 9:44 AMNascent Announces the Completion of Its Phase1 Clinical Trialsfinance.yahoo.com - February 28 at 9:44 AMNBIO Nascent Biotech, Inc.seekingalpha.com - February 14 at 6:32 PMNascent Biotech Inc.: Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trialfinanznachrichten.de - January 25 at 9:57 AMNascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trialfinance.yahoo.com - January 25 at 9:57 AMNascent Biotech Inc.: Nascent Enrolls Final Patient Cohort in Phase I Brain Cancer Trialfinanznachrichten.de - January 10 at 8:52 AMNascent Enrolls Final Patient Cohort in Phase I Brain Cancer Trialfinance.yahoo.com - January 10 at 8:52 AMNascent Biotech Inc.: Nascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory Boardfinanznachrichten.de - December 20 at 10:44 AMNascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory Boardfinance.yahoo.com - December 20 at 10:44 AMNascent Biotech Inc.: Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394finanznachrichten.de - November 2 at 4:32 PMNascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394finance.yahoo.com - November 1 at 9:35 AMNascent Biotech shares fall ~16%, on track for seventh session of losses in eightseekingalpha.com - October 6 at 9:39 AMNascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical Researchfinance.yahoo.com - October 4 at 12:35 PMNascent Biotech Inc.: Nascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancerfinanznachrichten.de - September 15 at 6:55 PMNascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancerfinance.yahoo.com - September 13 at 8:24 AMNascent Biotech - Changing the Biotechnology Industryapnews.com - August 28 at 6:57 PMNascent Biotech, Inc. (NBIO)finance.yahoo.com - August 27 at 10:02 PMChina Dongsheng International Change of Officers and Directorsnz.finance.yahoo.com - August 16 at 8:54 PMNascent Biotech Inc.: Nascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patentfinanznachrichten.de - July 19 at 8:50 AMNascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patentfinance.yahoo.com - July 19 at 8:50 AMNascent Biotech Inc.: Nascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancerfinanznachrichten.de - June 7 at 8:27 AMNascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancerfinance.yahoo.com - June 7 at 8:27 AMNascent Biotech Inc.: Nascent Biotech's CEO Sean Carrick Featured in In-Depth Interview with Proactive Investorsfinanznachrichten.de - May 6 at 1:31 AMNascent Biotech approaching final cohort for its Phase I clinical study to treat brain cancerproactiveinvestors.com - May 4 at 9:36 AMNascent Biotech’s CEO Sean Carrick Featured in In-Depth Interview with Proactive Investorsapnews.com - May 4 at 9:36 AMNascent Biotech's CEO Sean Carrick Featured in In-Depth Interview with Proactive Investorsfinance.yahoo.com - May 4 at 9:36 AMNascent Biotech and BioTools Partner in the Fight Against Cancer Using ROA to Define the Higher Order Structure of PTB, a Unique Monoclonal Antibodyfinance.yahoo.com - April 12 at 8:55 AMThe Laurel Amtower Cancer Institute and Neuro-Oncology Center at Sharp HealthCare to Join Innovative Antibody Brain Cancer Drug Trialfinance.yahoo.com - March 8 at 1:03 PM Get Nascent Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… NBIO Media Mentions By Week NBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBIO News Sentiment▼0.000.44▲Average Medical News Sentiment NBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBIO Articles This Week▼00▲NBIO Articles Average Week Get Nascent Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NBIO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nascent Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
